| Case Report: Regenerative peptides for Inferior alveolar nerve injury: a narrative review with hypothesis-generating three clinical cases.Front Oral Health | Case reports | 2026 |
| Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review.Pharmaceuticals (Basel) | Review of studies | 2026 |
| BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence.Int J Mol Sci | Review of studies | 2026 |
| Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.Curr Pain Headache Rep | Review of studies | 2026 |
| Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards.Int J Pharm Compd | Review of studies | 2026 |
| Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.Curr Sports Med Rep | Review of studies | 2026 |
| BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers.Pharmaceutics | Review of studies | 2026 |
| Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.JBJS Rev | Review of studies | 2026 |
| Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.Int J Mol Sci | Review of studies | 2026 |
| Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.Front Aging | Review of studies | 2026 |
| Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation.Integr Med (Encinitas) | Review of studies | 2026 |
| From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.Int J Mol Sci | Review of studies | 2026 |
| Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.Pharmaceuticals (Basel) | Review of studies | 2026 |
| Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review.Pharmaceuticals (Basel) | Review of studies | 2026 |
| Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias.Pharmaceuticals (Basel) | Review of studies | 2026 |
| Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.J Am Acad Orthop Surg Glob Res Rev | Review of studies | 2026 |
| Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.Am J Sports Med | Review of studies | 2026 |
| Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.Curr Rev Musculoskelet Med | Review of studies | 2025 |
| Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the "Triad" of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy.Pharmaceuticals (Basel) | Review of studies | 2025 |
| Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.HSS J | Review of studies | 2025 |
| Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.Pharmaceuticals (Basel) | Review of studies | 2025 |
| Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 Solution.Pharmaceuticals (Basel) | Review of studies | 2025 |
| Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.Pharmaceuticals (Basel) | Review of studies | 2025 |
| New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotection.Inflammopharmacology | Review of studies | 2024 |
| Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review.Pharmaceuticals (Basel) | Review of studies | 2024 |
| The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity.Pharmaceuticals (Basel) | Review of studies | 2024 |
| From Selye's and Szabo's Cysteamine-Duodenal Ulcer in Rats to Dopamine in the Stomach: Therapy Significance and Possibilities.Pharmaceuticals (Basel) | Review of studies | 2023 |
| Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions.Pharmaceuticals (Basel) | Review of studies | 2023 |
| Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function.Pharmaceuticals (Basel) | Review of studies | 2023 |
| Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle.Biomedicines | Review of studies | 2022 |
| Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation.Biomedicines | Review of studies | 2022 |
| Pentadecapeptide BPC 157 and the central nervous system.Neural Regen Res | Review of studies | 2022 |
| Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.Front Pharmacol | Review of studies | 2021 |
| Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future.Gut Liver | Review of studies | 2020 |
| BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection.Curr Pharm Des | Review of studies | 2020 |
| Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy.Curr Pharm Des | Review of studies | 2020 |
| Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.Cell Tissue Res | Review of studies | 2019 |
| BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.Curr Pharm Des | Review of studies | 2018 |
| BPC157 as Potential Agent Rescuing from Cancer Cachexia.Curr Pharm Des | Review of studies | 2018 |
| Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing.Curr Pharm Des | Review of studies | 2018 |
| "Stress" is 80 Years Old: From Hans Selye Original Paper in 1936 to Recent Advances in GI Ulceration.Curr Pharm Des | Review of studies | 2017 |
| Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?Curr Pharm Des | Review of studies | 2017 |
| Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.Curr Neuropharmacol | Review of studies | 2016 |
| BPC 157 and blood vessels.Curr Pharm Des | Review of studies | 2014 |
| Stable gastric pentadecapeptide BPC 157-NO-system relation.Curr Pharm Des | Review of studies | 2014 |
| Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.Curr Pharm Des | Review of studies | 2013 |
| Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157.Curr Med Chem | Review of studies | 2012 |
| Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.Curr Pharm Des | Review of studies | 2011 |
| Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.Curr Pharm Des | Review of studies | 2010 |
| Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.Inflammopharmacology | Review of studies | 2006 |
| A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC.J Physiol Paris | Review of studies | 1993 |
| Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis.Appl Biochem Biotechnol | In animals | 2026 |
| Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats.J Physiol Pharmacol | In animals | 2026 |
| Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury.Sci Rep | In animals | 2026 |
| Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia-Reperfusion Injury.Medicina (Kaunas) | In animals | 2025 |
| Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint.J Physiol Pharmacol | In animals | 2024 |
| Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect.World J Gastroenterol | In animals | 2023 |
| Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro.Life Sci | In animals | 2022 |
| Novel insight into Robert's cytoprotection: complex therapeutic effect of cytoprotective pentadecapeptide pentadecapeptide BPC 157 in rats with perforated stomach throughout modulation of nitric oxide-system. Comparison with L-arginine, ranitidine and pantoprazole therapy and L-NG-nitro-L-arginine methyl ester worsening.J Physiol Pharmacol | In animals | 2021 |
| Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.Behav Brain Res | In animals | 2021 |
| Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric Pentadecapeptide BPC 157.Drug Des Devel Ther | In animals | 2020 |
| Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway.Sci Rep | In animals | 2020 |
| The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats.Brain Behav | In animals | 2020 |
| Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds.Regul Toxicol Pharmacol | In animals | 2020 |
| Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot.Oxid Med Cell Longev | In animals | 2019 |
| Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME.Eur J Pharmacol | In animals | 2019 |
| Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation.Eur J Pharmacol | In animals | 2019 |
| Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) therapy, to control Nosema ceranae invasions in apiary conditions.J Vet Pharmacol Ther | In animals | 2018 |
| Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157.Vascul Pharmacol | In animals | 2018 |
| An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system.J Physiol Pharmacol | In animals | 2018 |
| BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats.Life Sci | In animals | 2017 |
| Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in rats.J Physiol Pharmacol | In animals | 2017 |
| Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: L-NAME, L-arginine, stable gastric pentadecapeptide BPC 157.Inflammopharmacology | In animals | 2017 |
| Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME.World J Gastroenterol | In animals | 2016 |
| Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats.PLoS One | In animals | 2016 |
| BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias.Eur J Pharmacol | In animals | 2016 |
| Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula.Eur J Pharmacol | In animals | 2016 |
| Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats.Life Sci | In animals | 2016 |
| NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs.Eur J Pharmacol | In animals | 2016 |
| BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental combination.Inflammopharmacology | In animals | 2015 |
| Duodenocutaneous fistula in rats as a model for "wound healing-therapy" in ulcer healing: the effect of pentadecapeptide BPC 157, L-nitro-arginine methyl ester and L-arginine.J Physiol Pharmacol | In animals | 2015 |
| Perforating corneal injury in rat and pentadecapeptide BPC 157.Exp Eye Res | In animals | 2015 |
| Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.Drug Des Devel Ther | In animals | 2015 |
| Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.PLoS One | In animals | 2015 |
| Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts.Molecules | In animals | 2014 |
| Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration.Eur J Pharmacol | In animals | 2014 |
| Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.J Physiol Pharmacol | In animals | 2013 |
| Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats.Med Sci Monit Basic Res | In animals | 2013 |
| Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.Eur J Pharmacol | In animals | 2013 |
| Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.Thromb Res | In animals | 2012 |
| Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.Eur J Pharmacol | In animals | 2011 |
| Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions.Life Sci | In animals | 2011 |
| Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat.J Orthop Res | In animals | 2010 |
| High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736).J Physiol Pharmacol | In animals | 2010 |
| Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application.Med Sci Monit | In animals | 2010 |
| Traumatic brain injury in mice and pentadecapeptide BPC 157 effect.Regul Pept | In animals | 2010 |
| Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury.Regul Pept | In animals | 2010 |
| Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing.J Physiol Pharmacol | In animals | 2009 |
| Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice.J Physiol Pharmacol | In animals | 2009 |
| Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy.J Physiol Pharmacol | In animals | 2009 |
| Antiinflammatory effect of BPC 157 on experimental periodontitis in rats.J Physiol Pharmacol | In animals | 2009 |
| Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats.J Physiol Pharmacol | In animals | 2009 |
| Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats.Dig Dis Sci | In animals | 2009 |
| Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system.Regul Pept | In animals | 2009 |
| Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole.Dig Dis Sci | In animals | 2009 |
| Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.J Pharmacol Sci | In animals | 2008 |
| Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone.Inflamm Res | In animals | 2008 |
| Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat.Surg Today | In animals | 2008 |
| Investigational Peptides in Orthopaedic Practice: Evidence, Safety, and Patient Counseling for BPC-157, Thymosin Beta-4, and TB-500.J Am Acad Orthop Surg | Other paper | 2026 |
| Peptide Supplements and Their Therapeutic Applications in Sports Medicine.Am J Sports Med | Other paper | 2026 |
| Fabrication and characterization of biocompatible BPC-157 based chitosan hydrogel.3 Biotech | Other paper | 2026 |
| Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.Analyst | Other paper | 2026 |
| Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach.Pharmaceuticals (Basel) | Other paper | 2026 |
| BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase.Int J Mol Sci | Other paper | 2026 |
| Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery.J Clin Med | Other paper | 2026 |
| Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.Curr Neuropharmacol | Other paper | 2026 |
| BPC157 drives angiogenesis through FBXO22-dependent stabilization of BACH1.Cell Commun Signal | Other paper | 2026 |
| Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in Rats.Pharmaceuticals (Basel) | Other paper | 2026 |
| Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats.Pharmaceuticals (Basel) | Other paper | 2026 |
| Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT).Inflammopharmacology | Other paper | 2025 |
| Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.Curr NeuropharmacolRetracted | Other paper | 2025 |
| Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats.Pharmaceutics | Other paper | 2025 |
| Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado.J Pharm Policy Pract | Other paper | 2025 |
| Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats.Pharmaceuticals (Basel) | Other paper | 2023 |
| Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in Doping Control by UHPLC-HRMS.Molecules | Other paper | 2023 |
| Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats.Pharmaceuticals (Basel) | Other paper | 2023 |
| Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy.Pharmaceuticals (Basel) | Other paper | 2023 |
| Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy.Pharmaceuticals (Basel) | Other paper | 2023 |
| Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.Front Pharmacol | Other paper | 2022 |
| Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157.Biomedicines | Other paper | 2022 |
| BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling "Negative-Like" Symptoms of Schizophrenia.Biomedicines | Other paper | 2022 |
| Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats.Biomedicines | Other paper | 2022 |
| Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy.Curr Issues Mol Biol | Other paper | 2022 |
| The anti-nociceptive effect of BPC-157 on the incisional pain model in rats.J Dent Anesth Pain Med | Other paper | 2022 |
| Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats.Biomedicines | Other paper | 2022 |
| Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma.Biomedicines | Other paper | 2021 |
| Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats.Front Pharmacol | Other paper | 2021 |
| BPC 157 as Potential Treatment for COVID-19.Med Hypotheses | Other paper | 2021 |
| Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats.Biomedicines | Other paper | 2021 |
| Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157.Biomedicines | Other paper | 2021 |
| Robert's Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157.Biomedicines | Other paper | 2021 |
| Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats.Biomedicines | Other paper | 2021 |
| Physiological and Immunological Status of Adult Honeybees (Apis mellifera) Fed Sugar Syrup Supplemented with Pentadecapeptide BPC 157.Biology (Basel) | Other paper | 2021 |
| Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats.Biomedicines | Other paper | 2021 |
| Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal.Biomedicines | Other paper | 2021 |
| Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157.Biomedicines | Other paper | 2021 |
| BPC 157 Therapy and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment.Biomedicines | Other paper | 2021 |
| BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats.Front Pharmacol | Other paper | 2021 |
| Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension.Biomedicines | Other paper | 2021 |
| Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats.World J Gastrointest Pharmacol Ther | Other paper | 2020 |
| Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats.Acta Clin Croat | Other paper | 2020 |
| In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro.Emerg Med Int | Other paper | 2020 |
| Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion.World J Hepatol | Other paper | 2020 |
| Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats.World J Gastrointest Pathophysiol | Other paper | 2020 |
| Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats.J Orthop Surg Res | Other paper | 2019 |
| Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine.World J Gastroenterol | Other paper | 2018 |
| Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine.World J Gastroenterol | Other paper | 2018 |
| Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities.Appl Microbiol Biotechnol | Other paper | 2018 |
| Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights.World J Gastroenterol | Other paper | 2017 |